This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzariol, A.
Right arrow Articles by Cornaglia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzariol, A.
Right arrow Articles by Cornaglia, G.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2003, p. 1738-1739, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1738-1739.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Isolation from Blood Culture of a Leclercia adecarboxylata Strain Producing an SHV-12 Extended-Spectrum Beta-Lactamase

Annarita Mazzariol, Jessica Zuliani, Roberta Fontana, and Giuseppe Cornaglia*

Department of Pathology, Microbiology Section, University of Verona, Verona, Italy

Received 25 July 2002/ Returned for modification 17 November 2002/ Accepted 7 January 2003


arrow
ABSTRACT
 
We report on the first isolation of an extended-spectrum beta-lactamase-producing Leclercia adecarboxylata strain from the bloodstream in a 58-year-old man with acute myeloid leukemia. The strain, resistant to ceftazidime, cefotaxime, and aztreonam, produces the SHV-12 ß-lactamase, one of the most common variants found in Italian nosocomial isolates of Enterobacteriaceae.


arrow
TEXT
 
Leclercia adecarboxylata, first described by Leclerc in 1962 as Escherichia adecarboxylata (5) and formerly also known as Enteric group 41, is a motile, gram-negative bacillus of the Enterobacteriaceae family (13, 15) and is rarely isolated from environmental and clinical specimens.

In clinical specimens, it has been found primarily as one of the components of polymicrobial wound infections (8, 15). Infections caused by L. adecarboxylata alone, as determined by the results of blood cultures, have been found only in immunocompromised patients (2, 10, 16).

L. adecarboxylata VR-01-1 was isolated in August 2001 from a blood culture of a 58-year-old man with acute myeloid leukemia admitted to the hematology unit of the Verona University Hospital. The strain was initially identified with biochemical tests by means of API ID32E (Biomérieux, Marcy l’Etoile, France). The identification was confirmed by the 16S rRNA gene sequence; the gene was amplified by using primers and the conditions reported by Woo et al. (17). The sequence was obtained with an ABI PRISM 377 automated sequencer (Perkin-Elmer) in accordance with the manufacturer's recommendations and compared with the known 16S rRNA gene sequences in GenBank, with no resulting detectable difference.

This isolate showed a behavior typical of extended-spectrum beta-lactamase (ESBL)-producing strains in the Kirby-Bauer test—namely, it presented resistance to ceftazidime, cefotaxime, aztreonam, and cefepime, and these resistances were reversed by clavulanic acid; this finding had never been described before in this species.

The isolate was also tested for its antimicrobial susceptibilities by broth microdilution in Müeller-Hinton medium at 37°C with a standard inoculum (9). The antimicrobials were all obtained from commercial sources. The MICs obtained for L. adecarboxylata VR-01-1 are reported in Table 1. The susceptibility pattern proved compatible with the presence of an ESBL that is capable of hydrolyzing ceftazidime, cefotaxime, and aztreonam, but not cephamycins, and that is susceptible to the common inhibitors.


View this table:
[in this window]
[in a new window]
  		TABLE 1. MICs for L. adecarboxylata and E. coli XL10 strains

The ß-lactamase production was first confirmed by isoelectric focusing. Cells were harvested after overnight growth in brain heart infusion broth and collected by centrifugation, and the pellet was resuspended in physiological solution. The cell content was released by sonication with a Labsonic 2000 sonicator (B. Braun Melsungen AG, Melsungen, Germany). Isoelectric focusing was performed in a precast polyacrylamide (5%) gel containing ampholines (pH range, 3.5 to 9.0) (Amersham Pharmacia Biotech, Uppsala, Sweden) on a Bio-Phoresis apparatus (Bio-Rad, Hercules, Calif.). Enzyme activity was revealed by overlaying the gel with a paper filter soaked in 250 µM nitrocefin (Oxoid, Basingstoke, Hampshire, England). The strain showed only one band with a pI of 8.2 (data not shown).

The presence of blaTEM or blaSHV resistance genes was checked by PCR. The oligonucleotide primers used for the PCR assays were as follows. TEM-FW and TEM-REV, specific for blaTEM (7), were 5'-ATAAAATTCTTGAAGACGAAA and 5'-GACAGTTACCAATGCTTAATCA, respectively; SHV-FW and SHV-REV, specific for blaSHV (12), were 5'-GGGTTATTCTTATTTGTCGC and 5'-TTAGCGTTGCCAGTGCTC, respectively.

The PCR conditions were 94°C 1 for min, 58°C for 1 min, and 72°C for 1 min for 35 cycles. For direct sequencing, PCR products were purified with a Qiagen microspin apparatus (Qiagen GmbH, Hilden, Germany). L. adecarboxylata VR-01-1 showed an SHV-type gene which, after sequencing, was identified as an SHV-12 ß-lactamase gene.

The gene was cloned in the phagemid vector pPCR Script Cam SK+ (Stratagene, La Jolla, Calif.). The entire SHV-12 gene was amplified by PCR with the primers SHV-CF (5'-GGGGAATTCTTATTTGTCGC) and SHV-CR (5'-CAGAATTCGCTTAGCGTTGCCAGT).

The PCR product was ligated with the phagemid vector pPCR Script Cam SK+. This cloning vector has a chloramphenicol resistance gene and a lac promoter for gene expression. Ligated vectors were transformed in Escherichia coli XL10 ultracompetent cells by the ligation kit polishing protocol (Stratagene). Transformants were selected on a Luria-Bertani agar plate with 30 µg of chloramphenicol/ml and then checked by PCR and endonuclease digestion.

After ligating the SHV-12 PCR product of L. adecarboxylata VR-01-1 in the vector, we obtained the pAJ1 plasmid coding for SHV-12 ß-lactamase.

The pAJ1 plasmid was transferred into the E. coli XL10 host cells, and mutants were selected on Luria-Bertani agar plates containing 30 µg of chloramphenicol/ml.

Both L. adecarboxylata VR-01-1 and the E. coli XL10/pAJ1 strain showed a band of pI 8.2 in the isoelectric focusing, while the E. coli XL10, harboring the vector alone, showed no such band, thus confirming the successful cloning.

Table 1 gives the MICs of a number of antimicrobial agents for L. adecarboxylata VR-01-1, E. coli XL10 harboring the plasmid pAJ1, and E. coli XL10 harboring only the vector pPCR Script Cam SK+. The results show that the SHV-12 ß-lactamase was responsible for increased MICs of ampicillin (>32 times), cephaloridine (32 times), penicillin G (>4 times), ceftazidime (256 times), cefotaxime (>64 times), cefuroxime (4 times), cefpirome (>32 times), and aztreonam (256 times). These MICs were the same in L. adecarboxylata VR-01-1 and E. coli XL10/pAJ1.

To investigate where the SHV-12 gene of L. adecarboxylata VR-01-1 was located, the plasmidic DNA was extracted from L. adecarboxylata with a Qiagen kit. We were able to amplify the SHV-12 gene from the plasmidic DNA of L. adecarboxylata, but all attempts to transfer the plasmid into E. coli XL10 or E. coli DH5{alpha} host cells by electroporation proved unsuccessful.

The world literature reports only nine cases of L. adecarboxylata over the past 10 years (1, 2, 3, 4, 6, 8, 14, 16), and most of them are quite recent.

The isolation of L. adecarboxylata VR-01-1 from the bloodstream of a patient with acute myeloid leukemia confirms that infections by L. adecarboxylata alone can be found only in patients whose immune defenses are compromised by an underlying medical condition, while in otherwise healthy adults, this microorganism is found primarily as just one of the components of a polymicrobial infection.

Testing antimicrobial agents in all the L. adecarboxylata strains reported to date has demonstrated pansensitivity. Thus, the presence of an ESBL in an isolate of this species and its location on a transposable element are disquieting findings which may be a prelude to the wider diffusion of this microorganism.

The identification of the L. adecarboxylata VR-01-1 ESBL as an SHV-12 ß-lactamase confirms the widespread diffusion in Italy of this enzyme, which was one of the most common variants found in most hospitals and in several different species of Enterobacteriaceae in a recent Italian nationwide survey (11).


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Dipartimento di Patologia, Sezione di Microbiologia, Strada Le Grazie, 8, 37134 Verona, Italy. Phone: 0039-045-8027196. Fax: 0039-045-584606. E-mail: giuseppe.cornaglia{at}univr.it. Back


arrow
REFERENCES
 
    1
  1. Cai, M., X. Dong, J. Wei, F. Yang, D. Xu, H. Zhang, X. Zheng, S. Wang, and H. Jin. 1992. Isolation and identification of Leclercia adecarboxylata in clinical isolates in China. Wei Sheng Wu Xue Bao 32:119-123.[Medline]
    2. 2
  2. Daza, R. M., J. Iborra, N. Alonso, I. Vera, F. Portero, and P. Mendaza. 1993. Isolation of Leclercia adecarboxylata in a cirrhotic patient. Enferm. Infecc. Microbiol. Clin. 11:53-54.[Medline]
    3. 3
  3. De Daere, T., G. Wauters, A. Huylenbroeck, G. Claeys, R. Peleman, G. Verschraegen, D. Allemeersch, and M. Vaneechoutte. 2001. Isolation of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus. J. Clin. Microbiol. 39:1674-1675.[Abstract/Free Full Text]
    4. 4
  4. Fattal, O., and J. G. Deville. 2000. Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis. Pediatr. Nephrol. 16:186-187.[CrossRef]
    5. 5
  5. Leclerc, H. 1962. Etude biochimique d'enterobacteriaceae pigmentées. Ann. Inst. Pasteur. 102:726-741.[Medline]
    6. 6
  6. Longhurst, C. A., and D. C. West. 2001. Isolation of Leclercia adecarboxylata from an infant with acute lymphoblastic leukemia. Clin. Infect. Dis. 32:1659.[Medline]
    7. 7
  7. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum ß-lactamases, p. 553-563. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
    8. 8
  8. Martinez, M. M., G. Sanchez, J. Gomez, P. Mendaza, and R. M. Daza. 1998. Isolation of Leclercia adecarboxylata in ulcer exudate. Enferm. Infecc. Microbiol. Clin. 16:345.[Medline]
    9. 9
  9. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 5th ed. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
    10. 10
  10. Otani, E., and D. A. Bruckener. 1991. Leclercia adecarboxylata isolated from blood culture. Clin. Microbiol. Newsl. 13:157-158.[CrossRef]
    11. 11
  11. Perilli, M., E. Dell'Amico, B. Segatore, M. R. de Massis, C. Bianchi, F. Luzzaro, G. M. Rossolini, A. Toniolo, G. Nicoletti, and G. Amicosante. 2002. Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40:611-614.[Abstract/Free Full Text]
    12. 12
  12. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.[Abstract]
    13. 13
  13. Richard, C. 1984. Nouvelles espèces d'enterobacteriaceae (1979-1983). Bull. l'Institut Pasteur 82:255-277.
    14. 14
  14. Rodriguez, J. A., F. J. Sanchez, N. Gutierrez, J. E. Garcia, and J. A. Garcia-Rodriguez. 2001. Bacterial peritonitis due to Leclercia adecarboxylata in a patient undergoing peritoneal dialysis. Enferm. Infecc. Microbiol. Clin. 19:237-238.[Medline]
    15. 15
  15. Tamura, K., R. Sakazaki, Y. Kosako, and E. Yoshizaki. 1986. Leclercia adecarboxylata gen. nov., comb. nov., formerly known as Escherichia adecarboxylata. Curr. Microbiol. 13:179-184.
    16. 16
  16. Temesgen, Z., D. R. Toal, and F. R. Cockerill. 1997. Leclercia adecarboxylata infections: case report and review. Clin. Infect. Dis. 25:79-81.[Medline]
    17. 17
  17. Woo, P. C. Y., E. Y. L. Cheung, K. Leung, and K. Yuen. 2001. Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species with ambiguous biochemical profile from renal transplant recipient. Diagn. Microbiol. Infect. Dis. 39:85-93.[CrossRef][Medline]

Journal of Clinical Microbiology, April 2003, p. 1738-1739, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1738-1739.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Hess, B., Burchett, A., Huntington, M. K. (2008). Leclercia adecarboxylata in an immunocompetent patient. J Med Microbiol 57: 896-898 [Abstract] [Full Text]  
  • Valverde, A., Coque, T. M., Sanchez-Moreno, M. P., Rollan, A., Baquero, F., Canton, R. (2004). Dramatic Increase in Prevalence of Fecal Carriage of Extended-Spectrum {beta}-Lactamase-Producing Enterobacteriaceae during Nonoutbreak Situations in Spain. J. Clin. Microbiol. 42: 4769-4775 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzariol, A.
Right arrow Articles by Cornaglia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzariol, A.
Right arrow Articles by Cornaglia, G.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»